---
title: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter"
date: 2022-05-02
enddate:
---

Published in: *Neuro-Oncology*

DOI: [10.1093/neuonc/noac116](https://doi.org/10.1093/neuonc/noac116)

<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/800px-Open_Access_logo_PLoS_transparent.svg.png" alt="drawing" width="50" align="left"/> &nbsp;&nbsp;&nbsp;This publication is available in **Open Access**! (Hybrid OA)

&nbsp;&nbsp;&nbsp;<a href="https://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noac116/43927206/noac116.pdf">Access it freely here</a>

